The use of objective case ascertainment to identify risk factors for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder in pediatric liver transplant recipients.

被引：0
|
作者：
Guthery, SL
Heubi, JE
Bucuvalas, J
Gross, TG
Ryckman, FC
Alonso, MH
Balistreri, WF
Hornung, RW
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[2] Univ Cincinnati, Inst Hlth Policy & Hlth Serv Res, Cincinnati, OH USA
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1995
引用
收藏
页码：662A / 662A
页数：1
相关论文
共 50 条
  • [1] Epstein-Barr virus-associated risk factors for post-transplant lymphoproliferative disease in pediatric liver transplant recipients
    Quintero Bernabeu, Jesus
    Juamperez, Javier
    Mercadal-Hally, Maria
    Larrarte King, Mauricio
    Gallego Melcon, Soledad
    Gros Subias, Luis
    Sabado Alvarez, Constantino
    Soler-Palacin, Pere
    Melendo Perez, Susana
    Esperalba, Juliana
    Navarro Jimenez, Alexandra
    Garrido Pontnou, Marta
    Camacho Soriano, Jessica
    Hidalgo Llompart, Ernest
    Bilbao Aguirre, Itxarone
    Charco Torra, Itzarone
    PEDIATRIC TRANSPLANTATION, 2022, 26 (06)
  • [2] Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery, SL
    Heubi, JE
    Bucuvalas, JC
    Gross, TG
    Ryckman, FC
    Alonso, MH
    Balistreri, WF
    Hornung, RW
    TRANSPLANTATION, 2003, 75 (07) : 987 - 993
  • [3] Epstein-Barr virus-associated post-transplant lymphoproliferative disorder
    Bar-Natan, M
    Nagler, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (03): : 205 - 207
  • [4] TacrolimusPulmonary post-transplant Epstein-Barr virus-associated lymphoproliferative disorder: case report
    Reactions Weekly, 2021, 1839 (1) : 287 - 287
  • [5] TacrolimusPulmonary post-transplant Epstein-Barr virus-associated lymphoproliferative disorder: case report
    Reactions Weekly, 2020, 1787 (1) : 456 - 456
  • [6] Idiopathic Pulmonary Fibrosis Lung Transplant Recipients are at Increased Risk for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorder
    Iasella, C. J.
    Winters, S.
    Kois, A.
    Cho, J.
    Hannan, S. J.
    Koshy, R.
    Moore, C.
    Lendermon, E. A.
    Pilewski, J.
    Morrell, M.
    Sanchez, P. G.
    Kass, D.
    Alder, J. K.
    Nouriea, S. M.
    McDyer, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S382 - S383
  • [7] Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
    Chang, Yeh-Chung
    Young, Rebecca R.
    Mavis, Alisha M.
    Chambers, Eileen T.
    Kirmani, Sonya
    Kelly, Matthew S.
    Kalu, Ibukunoluwa C.
    Smith, Michael J.
    Lugo, Debra J.
    PLOS ONE, 2022, 17 (10):
  • [8] EPSTEIN-BARR VIRUS (EBV) INFECTION IS A RISK FACTOR FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS
    Gulati, A.
    Yeo, W. S.
    Aragon, E. T.
    Lau, Y. W.
    Ng, K. H.
    Yap, H. K.
    PEDIATRIC NEPHROLOGY, 2009, 24 (03) : 678 - 678
  • [9] Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients
    Köpf, S
    Tönshoff, B
    PEDIATRIC NEPHROLOGY, 2004, 19 (04) : 365 - 368
  • [10] Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients
    Sabine Köpf
    Burkhard Tönshoff
    Pediatric Nephrology, 2004, 19 : 365 - 368
12345